Format
Sort by

Send to

Choose Destination

Links from Books

Items: 10

1.

Germline deletion of the miR-17∼92 cluster causes skeletal and growth defects in humans.

de Pontual L, Yao E, Callier P, Faivre L, Drouin V, Cariou S, Van Haeringen A, Geneviève D, Goldenberg A, Oufadem M, Manouvrier S, Munnich A, Vidigal JA, Vekemans M, Lyonnet S, Henrion-Caude A, Ventura A, Amiel J.

Nat Genet. 2011 Sep 4;43(10):1026-30. doi: 10.1038/ng.915.

2.

Genotype-phenotype correlations in MYCN-related Feingold syndrome.

Marcelis CL, Hol FA, Graham GE, Rieu PN, Kellermayer R, Meijer RP, Lugtenberg D, Scheffer H, van Bokhoven H, Brunner HG, de Brouwer AP.

Hum Mutat. 2008 Sep;29(9):1125-32. doi: 10.1002/humu.20750.

PMID:
18470948
3.

Activities of N-Myc in the developing limb link control of skeletal size with digit separation.

Ota S, Zhou ZQ, Keene DR, Knoepfler P, Hurlin PJ.

Development. 2007 Apr;134(8):1583-92. Epub 2007 Mar 14.

4.

Growth deficiency in oculodigitoesophagoduodenal (Feingold) syndrome--case report and review of the literature.

Shaw-Smith C, Willatt L, Thalange N.

Clin Dysmorphol. 2005 Jul;14(3):155-8. Review.

PMID:
15930908
5.

MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome.

van Bokhoven H, Celli J, van Reeuwijk J, Rinne T, Glaudemans B, van Beusekom E, Rieu P, Newbury-Ecob RA, Chiang C, Brunner HG.

Nat Genet. 2005 May;37(5):465-7. Epub 2005 Apr 10.

PMID:
15821734
6.

The MYCN oncoprotein as a drug development target.

Lu X, Pearson A, Lunec J.

Cancer Lett. 2003 Jul 18;197(1-2):125-30. Review.

PMID:
12880971
8.

Identification of N-myc regulatory regions involved in embryonic expression.

Charron J, Gagnon JF, Cadrin-Girard JF.

Pediatr Res. 2002 Jan;51(1):48-56.

PMID:
11756639
Items per page

Supplemental Content

Write to the Help Desk